Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,790.00p
   
  • Change Today:
      24.00p
  • 52 Week High: 6,070.00p
  • 52 Week Low: 2,234.00p
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 61,787
  • Market Cap: £1,835.08m
  • RiskGrade: 128

Latest ShareCast News

Genus FY profits slip as weak Chinese PIC performance weighs

By Iain Gilbert

Date: Thursday 24 Feb 2022

(Sharecast News) - Biotechnology company Genus said on Thursday that full-year profits had slipped in 2021 as the group's performance was impacted by the performance of its PIC unit in China.

Director dealings: Genus chairman makes share purchase

By Iain Gilbert

Date: Thursday 25 Nov 2021

(Sharecast News) - Genus revealed on Thursday that chairman Iain Ferguson had acquired 1,000 ordinary shares in the FTSE 250-listed biotechnology firm.

Genus sees FY profit 'moderately' below its expectations

By Michele Maatouk

Date: Wednesday 24 Nov 2021

(Sharecast News) - Animal genetics company Genus said on Wednesday that based on current trading, especially in China, pre-tax profit for 2022 is set to be "moderately lower" than its previous expectations.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,790.00p
Change Today 24.00p
% Change 0.87 %
52 Week High 6,070.00p
52 Week Low 2,234.00p
Volume 61,787
Shares Issued 65.77m
Market Cap £1,835.08m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.86% below the market average94.86% below the market average94.86% below the market average94.86% below the market average94.86% below the market average
92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average
Price Trend
66.98% below the market average66.98% below the market average66.98% below the market average66.98% below the market average66.98% below the market average
6.25% below the sector average6.25% below the sector average6.25% below the sector average6.25% below the sector average6.25% below the sector average
Income
87.56% below the market average87.56% below the market average87.56% below the market average87.56% below the market average87.56% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Growth
42.69% above the market average42.69% above the market average42.69% above the market average42.69% above the market average42.69% above the market average
64.10% above the sector average64.10% above the sector average64.10% above the sector average64.10% above the sector average64.10% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Mar-22 18-Nov-21
Paid 31-Mar-22 10-Dec-21
Amount 10.30p 21.70p

Trades for 08-Aug-2022

Time Volume / Share Price
16:35 26,480 @ 2,790.00p
16:29 75 @ 2,804.00p
16:28 20 @ 2,810.00p
16:28 7 @ 2,810.00p
16:28 9 @ 2,810.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page